XORTX Therapeutics XRTX
NASDAQ XRTX
$0.97 -0.02 (-2.02%)
As of: Oct 21, 2026 · 11:34 AM EDT

XORTX Therapeutics (XRTX) Revenue (2023)

Updated

Analysis

XORTX Therapeutics (XRTX) Revenue (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,130.38 Bn 1,098.96 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 613.84 Bn 532.37 Bn 17.26 Bn 25.31 Bn
3 AbbVie 502.13 Bn 475.24 Bn 12.70 Bn 16.99 Bn
4 Merck 367.76 Bn 322.14 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.08 Bn 262.07 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 262.03 Bn 235.71 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.81 Bn 191.21 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn 15.03 Bn
10 XORTX Therapeutics 994,273.30 -2.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.70 Mn
Sep 30, 2023 1.33 Mn
Jun 30, 2023 1.69 Mn
Mar 31, 2023 1.83 Mn
API Access

XORTX Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=XRTX&period=max&api_key=YOUR_API_KEY